News

Published on 31 Aug 2022 on Zacks via Yahoo Finance

Aerie (AERI) Rallies 205.6% in the Past Three Months: Here's Why


Article preview image

Shares of Aerie Pharmaceuticals AERI have skyrocketed in the past three months, outpacing other medical stocks in the industry after the company announced its acquisition deal with Alcon Pharmaceuticals ALC.

AERI shares have surged 137.5% in the past month against the industry’s decline of 2.6%.

Zacks Investment ResearchZacks Investment Research

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
3 Beaten-Down Stocks to Buy and Hold

With this in mind, we asked three Motley Fool contributors to pick beaten-down stocks to buy and ...

Motley Fool 15 Oct 2022

Why Shares of Keros Therapeutics Rose 10.2% This Week

Jim Halley has no position in any of the stocks mentioned. The Motley Fool has positions in and...

Motley Fool 14 Oct 2022

Did The Texas ESG Ban Have Any Bite?

I tried to cross-tally the list of funds and companies banned by the Texas Comptroller with the p...

Forbes 14 Oct 2022

Kyverna Therapeutics Names Peter Maag, Ph.D., as Chief Executive Officer

Former chairman of CareDx, Inc. and seasoned global industry executive with track record of...

FOX 19 Cincinnati 13 Oct 2022

Pfizer: An Excellent Combinati - GuruFocus.com

The decline in the share price is slightly ahead of the 23.64% decrease in the S&P 500 Index. Lea...

Guru Focus 10 Oct 2022

Gastrointestinal Stromal Tumors Therapeutics Market Size to Grow by USD 1.08 Bn, Growing Geriatric...

NEW YORK, Oct. 9, 2022 /PRNewswire/ -- The "Gastrointestinal Stromal Tumors Therapeutics Market b...

The Longview News-Journal 9 Oct 2022

5 Stocks to Delete From Your Watchlist in Q4

Amid rising recession worries, we think fundamentally weak stocks, Advanced Micro Devices (AMD), ...

Entrpreneur 7 Oct 2022

Should First Trust Small Cap Growth AlphaDEX ETF (FYC) Be on Your Investing Radar?

Launched on 04/19/2011, the First Trust Small Cap Growth AlphaDEX ETF (FYC) is a passively manage...

Zacks via Yahoo Finance 6 Oct 2022

Lennox-Gastaut Syndrome Treatment Market 2026, Rising Population With Risk Factors For LGS to Boost...

NEW YORK, Oct. 5, 2022 /PRNewswire/ -- The lennox-gastaut syndrome treatment market size is expec...

The Longview News-Journal 5 Oct 2022

Will Acquisitions Help Novo Nordisk (NVO) Combat Stiff Rivalry?

Denmark-based Novo Nordisk A/S NVO has one of the broadest diabetes portfolios in the industry. T...

Zacks via Yahoo Finance 3 Oct 2022